Myodenovo Inc.

Biotechnology company · Raleigh, North Carolina, United States

Myodenovo Inc. is a biotechnology company headquartered in Raleigh, North Carolina, United States. Its earliest recorded incorporation is in 2022. It has reported private securities offerings to the US SEC, most recently $105,000 sold in a notice filed in 2023.

Profile compiled from public records. Is this your company? Request a correction or update

Myodenovo at a glance

Typebiotechnology company

HeadquartersRaleigh, North Carolina, United States

Earliest incorporation on record2022

SEC CIK1960653

What does Myodenovo do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $105,000 sold (2023).

Frequently asked questions about Myodenovo

Where is Myodenovo headquartered?

Myodenovo Inc. is headquartered in Raleigh, North Carolina, United States.

What does Myodenovo do?

Myodenovo Inc. is a biotechnology company.

When was Myodenovo founded?

The earliest incorporation on record for Myodenovo Inc. is in 2022, according to public company registers.

Similar companies

Arrevus, Inc.Raleigh, North Carolina, United States
NuPulseCV, Inc.Raleigh, North Carolina, United States
GeneVentiv Therapeutics, Inc.Raleigh, North Carolina, United States
RainBio, Inc.Raleigh, North Carolina, United States
Aer Therapeutics, Inc.Raleigh, North Carolina, United States
Merz Pharmaceuticals, LLCRaleigh, North Carolina, United States
Glycan Therapeutics CorporationRaleigh, North Carolina, United States
Tribofilm Research IncRaleigh, North Carolina, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences